Pipeline

Research Pipeline

Sanare Bioscience’s research pipeline reflects responsible scientific development in areas of significant unmet public-health need. Our programs explore lipid science, toxicology, behavioral health, and cannabinoid-related emergencies through preclinical evaluation and expert collaboration.
Disclaimer:
No program is FDA-approved or proven safe or effective.
Pipeline

Sanare at a Glance

Sanare Bioscience’s research pipeline reflects responsible scientific development in areas of significant unmet public-health need. Our programs explore lipid science, toxicology, behavioral health, and cannabinoid-related emergencies through preclinical evaluation and expert collaboration.
Disclaimer:
No program is FDA-approved or proven safe or effective.
Pipeline

Research Pipeline

Sanare Bioscience’s research pipeline reflects responsible scientific development in areas of significant unmet public-health need. Our programs explore lipid science, toxicology, behavioral health, and cannabinoid-related emergencies through preclinical evaluation and expert collaboration.
Disclaimer:
No program is FDA-approved or proven safe or effective.
Pipeline

Sanare at a Glance

Sanare Bioscience’s research pipeline reflects responsible scientific development in areas of significant unmet public-health need. Our programs explore lipid science, toxicology, behavioral health, and cannabinoid-related emergencies through preclinical evaluation and expert collaboration.
Disclaimer:
No program is FDA-approved or proven safe or effective.
Pipeline

Sanare at a Glance

Sanare Bioscience is a clinical-stage biotechnology company that integrates systems from research to market analysis, aiming to improve patient outcomes through innovative therapies and rigorous scientific research.
Pipeline
Research

Sanare at a Glance

Sanare Bioscience’s research pipeline reflects responsible scientific development in areas of significant unmet public-health need. Our programs explore lipid science, toxicology, behavioral health, and cannabinoid-related emergencies through preclinical evaluation and expert collaboration.

Disclaimer:
No program is FDA-approved or proven safe or effective.

Services

Services

Services

Research & Development

Formulation investigation for improved drug delivery
Toxicology-based safety insights in early research
Preclinical planning and evaluation pathways

Regulatory & Compliance

Guidance on research, data collection, and reporting
Risk management and scientific best-practice alignment

Partnerships & Commercialization

Collaboration with distribution and healthcare networks
Scientific engagement and community awareness initiatives

Public-Health Support

Evidence-based outreach for cannabinoid-related challenges
Responsible scientific communication and advocacy

Research & Development

Formulation investigation for improved drug delivery
Toxicology-based safety insights in early research
Preclinical planning and evaluation pathways

Regulatory & Compliance

Guidance on research, data collection, and reporting
Risk management and scientific best-practice alignment

Partnerships & Commercialization

Collaboration with distribution and healthcare networks
Scientific engagement and community awareness initiatives

Public-Health Support

Evidence-based outreach for cannabinoid-related challenges
Responsible scientific communication and advocacy

Advocacy & Awareness Engine

Advocacy & Awareness Engine

Advocacy & Awareness Engine

Sanare Bioscience supports education and responsible dialogue around cannabis intoxication and CHS through a collaborative network of clinicians, advocates, and community-health partners.

Engagement and advocacy participation do not imply clinical endorsement.

Sanare Bioscience supports education and responsible dialogue around cannabis intoxication and CHS through a collaborative network of clinicians, advocates, and community-health partners.

Engagement and advocacy participation do not imply clinical endorsement.

33,000+ Patient Community

Education engagement

Click for more info

12,000+ Healthcare Professionals

Clinical outreach

Click for more info

State Briefings

Expert participation in 20+ Poison Center engagements

Click for more info

Policy & Community Engagement

Supporting public-health dialogue

Click for more info

Media Participation

Sharing science-based awareness

Click for more info

Credible Ambassadors

Community public-health supporters

Click for more info

Competitive Landscape: Limited Clinical-Stage Efforts Exist

Competitive Landscape: Limited Clinical-Stage Efforts Exist

Competitive Landscape: Limited Clinical-Stage Efforts Exist

Cannabinoid-intoxication treatment remains largely unaddressed, with only one other investigational program in clinical development. Cerebro-1’s lipid-sink research supports scientific differentiation in safety, speed, and potential clinical utility.

Cannabinoid-intoxication treatment remains largely unaddressed, with only one other investigational program in clinical development. Cerebro-1’s lipid-sink research supports scientific differentiation in safety, speed, and potential clinical utility.

Approach

Mechanism

Risk Profile

Key Differentiation

CB1 Antagonist (e.g., ANEB001

Blocks THC at CB1

receptors

High psychiatric side

effects

Slow onset, limited emergency utility, black-box risk

Cerebro-1 Lipid Sink)

Extracts THC from circulation

Very low safety concerns

Rapid onset, no receptor blockade, established safety profile

No Need for Receptor Blockade

Our mechanism bypasses CB1 antagonism entirely, avoiding the psychiatric liability that plagued earlier cannabinoid drugs (e.g., Rimonabant withdrawal)

Click for more info

Rapid Onset Potential

Lipid sink action begins immediately upon infusion, potentially shortening symptom duration from hours to minutes

Click for more info

Proven Safety Class

Lipid emulsions are widely used in clinical practice for nutrition and toxin extraction, with well-characterized safety profiles

Click for more info

Public Health Need: Cannabis Intoxication
& CHS


Public Health Need: Cannabis Intoxication
& CHS


Public Health Need: Cannabis Intoxication
& CHS


Emergency cases involving cannabis intoxication and CHS are rising across youth and adult populations in the U.S. and Canada. Increasing incidence and hospital strain highlight an urgent need for scientific investigation. No FDA-approved treatments exist today.

Emergency cases involving cannabis intoxication and CHS are rising across youth and adult populations in the U.S. and Canada. Increasing incidence and hospital strain highlight an urgent need for scientific investigation. No FDA-approved treatments exist today.

49% Annual Increase

CHS emergency department visits up dramatically JAMA Network Open 2025

Click for more info

300% Rise Since 2020

Edible-related hospitalizations surging nationwide

Click for more info

32,000+ Patients

Documented in support groups seeking treatment options

Click for more info

Zero Approved

Hospitals lack FDA-approved interventions for acute cases

Click for more info

Early-stage scientific investigation is essential to better understand this emerging public health challenge and explore potential future pathways for intervention.

Early-stage scientific investigation is essential to better understand this emerging public health challenge and explore potential future pathways for intervention.

Scientific Areas of Investigation

Clinical Challenges Being Studied
• Severe vomiting episodes requiring emergency care
• Behavioral challenges and patient safety risks
• Fluid/electrolyte imbalance and dehydration
• Pain, nausea, and prolonged ED visits
• Patient distress and caregiver burden

Healthcare Environment Considerations
• Extended emergency department resource use
• Strain across hospital services
• Variability in clinical awareness and treatment
• Increasing exposure, risk, and readmissions

Retexo™ is our patented solution developed by Sanare Bioscience to support investigations into the body’s response to cannabinoid toxicity. It aims to address associated effects and support the central nervous and cardiovascular systems.

Retexo™ is our patented solution developed by Sanare Bioscience to support investigations into the body’s response to cannabinoid toxicity. It aims to address associated effects and support the central nervous and cardiovascular systems.

RETEXO ™

RETEXO ™

RETEXO ™

Introducing Retexo™ a THC treatment specifically formulated to help the human body clear THC more effectively.

Retexo™ functions by aiding the body's natural detoxification processes, helping to clear certain substances from vital areas such as the heart and brain. It provides quick relief for specific symptoms, supporting the body's overall recovery and well-being.

Partnering with Sanare

Partner with Sanare

Partnerships support research and awareness initiatives only. No products are commercially available.

We provide innovative solutions that work
to bridge gaps in the drug development business. 

Cerebro-1 is an investigational product candidate currently in early-stage development. It has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). No safety or efficacy has been established. All information on this website is for educational and research-oriented purposes only and is not medical advice.

© 2024 Sanare Bioscience. All rights reserved.

We provide innovative solutions that work
to bridge gaps in the drug development business. 

Cerebro-1 is an investigational product candidate currently in early-stage development. It has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). No safety or efficacy has been established. All information on this website is for educational and research-oriented purposes only and is not medical advice.

© 2024 Sanare Bioscience. All rights reserved.

We provide innovative solutions that work
to bridge gaps in the drug development business. 

Cerebro-1 is an investigational product candidate currently in early-stage development. It has not been evaluated or approved by the U.S. Food and Drug Administration (FDA). No safety or efficacy has been established. All information on this website is for educational and research-oriented purposes only and is not medical advice.

© 2024 Sanare Bioscience. All rights reserved.